MedTrace Logo

Study of Blood Lactate Levels in Patients Treated With Antipsychotics

NCT01139463 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2010-06-08

No results posted yet for this study

Summary

Blood lactate levels in patients receiving typical or atypical antipsychotics have not been described in the literature.

The goal of this study is to assess the dynamics of lactate levels in the blood from typical or atypical antipsychotics not confounded by prior antipsychotic treatments, the investigators conducted a prospective study of lactate levels in patients receiving antipsychotic medication. The investigators hypothesized that 6 months of treatment with haloperidol or olanzapine would result in a change in blood lactate levels and extrapyramidal side effects.

Conditions

Interventions

DRUG

Haloperidol or olanzapine

Haloperidol tablet - 5 mg twice daily (morning and evening) by mouth Olanzapine tablet - 5 mg twice daily (morning and evening) by mouth

Sponsors & Collaborators

  • University Hospital of Split

    lead OTHER

Principal Investigators

  • Trpimir Glavina, MD · University Hospital of Split

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • Croatia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01139463 on ClinicalTrials.gov